A recent study reported that CXCL9 and SPP1 are very rarely expressed in the same monocyte, and that the balance of CXCL9+ vs SPP1+ TAMs predict patient outcome for squamous cell carcinomas of the head and neck (33). This evidence concerns the gene CXCL9 and squamous cell carcinoma.